FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May. 4, 2012--
American Anesthesiology, a division of MEDNAX, Inc., (NYSE: MD) today
announced the acquisition of Brazos Anesthesiology Associates, P.A.
(BAA), a physician group practice based in Bryan, Texas that provides
anesthesia services, including cardiac, pediatric, obstetric, regional
anesthesia and chronic pain management, throughout the Brazos Valley.
The practice consists of 16 anesthesiologists who practice as part of an
anesthesia care team model that includes 29 anesthetists as well as
three pain care nurses. Serving the Brazos Valley community for more
than 24 years, BAA currently provides anesthesia services at St. Joseph
Regional Health Center in Bryan, College Station Medical Center in
College Station, and Physicians Center in Bryan, as well as eight other
locations. BAA is the second Texas-based practice to join American
Anesthesiology, with the other located in Austin, Texas.
“The combination of our longstanding commitment to providing anesthesia
services and pain care management will now be enhanced by the
infrastructure and administrative support services provided by American
Anesthesiology,” said Patrick Ryan, M.D., who will serve as medical
director of the practice. “We made the right choice for today’s changing
healthcare environment, one that will allow us to focus on providing our
patients with superior care.”
The physicians joining as a result of this transaction will now be part
of MEDNAX’s American Anesthesiology division, which consists of more
than 950 anesthesia providers, including more than 425 physicians and
525 anesthetists and anesthesia assistants practicing in North Carolina,
Virginia, Georgia, Florida, Texas, and New Jersey.
This practice was acquired for cash and the transaction is expected to
be immediately accretive to earnings. No additional terms of the
transaction were disclosed.
With this acquisition, two group practices have become part of American
Anesthesiology and four physician group practices have become part of
MEDNAX’s Pediatrix Medical Group in 2012.
ABOUT MEDNAX
MEDNAX, Inc., is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 300 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric critical care physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, MEDNAX expanded into anesthesia
services. Today, American Anesthesiology includes more than 950
anesthesiologists and advanced practitioners who provide anesthesia care
to patients in connection with surgical and other procedures as well as
pain management. MEDNAX, through its affiliated professional
corporations, employs more than 1,800 physicians in 34 states and Puerto
Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
Source: MEDNAX, Inc.
MEDNAX, Inc.
David T. Parker, 954-384-0175, x 5692
Vice
President, Investor Relations & Corporate Communications
david_parker@mednax.com